← 產業報告目錄

Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-06-29頁數 515報告編號 MD2157

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global hemodialysis and peritoneal dialysis market was valued at USD 102.7 billion in 2026 and is expected to reach USD 141.5 billion by 2031, growing at a CAGR of 6.6% during the forecast period. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), driven by increasing rates of diabetes, hypertension, and aging populations worldwide, is the primary force behind market expansion. Growing adoption of home-based dialysis therapies, supported by cost-containment policies in healthcare systems and payer reimbursement frameworks such as the Centers for Medicare & Medicaid Services (CMS) in the US, is broadening the patient base for both home hemodialysis and peritoneal dialysis. Expanding dialysis infrastructure in emerging markets across Asia Pacific, Latin America, and the Middle East and Africa is further adding to global patient volumes. High treatment costs and poor reimbursement for home hemodialysis in several markets outside North America remain constraints on faster adoption of home-based modalities. “The HD access products subsegment is expected to register the highest CAGR among HD consumables during the forecast period.” Among the HD consumables and supplies segments, HD access products are projected to grow at the highest CAGR during the forecast period. Vascular access is a prerequisite for every hemodialysis session, and the structural demand it creates is consistent across care settings. Clinical guidelines from the National Kidney Foundation's KDOQI protocols, which prioritize arteriovenous fistula creation as the preferred access method, are driving procedure volumes and associated product consumption. The increasing use of tunneled hemodialysis catheters as a bridge to permanent access, the expanding patient population requiring long-term access management, and growing demand for single-use access needles and securement products are all contributing to this segment's growth. Dialyzers, the second-fastest-growing subsegment, are also benefiting from rising clinical adoption of high-flux and medium-cut-off membrane technologies that improve middle-molecule clearance relative to standard membranes. “Hospitals accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025.” By end user, hospitals held the largest share of the global hemodialysis and peritoneal dialysis market in 2025. Hospital-based dialysis units manage the full clinical complexity of the ESRD and AKI patient population, including newly diagnosed patients, those with significant comorbidities, and critical care patients requiring continuous renal replacement therapy. The concentration of specialized nephrology staff, dialysis equipment, and emergency infrastructure within hospital settings makes them the default point of care for patients initiating treatment. Independent dialysis centers collectively represent the largest channel but are distributed across a fragmented operator landscape, while hospitals manage a disproportionate share of high-acuity and newly incident patients. Home care settings are growing at the fastest rate among end users, driven by cost pressures in the healthcare system and the expansion of home dialysis program infrastructure. “North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025, while Asia Pacific is expected to register the highest CAGR during the forecast period.” North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025. The US is the primary driver within this region, supported by a large and structurally growing ESRD patient population of more than 808,000 individuals, according to the United States Renal Data System 2023 Annual Data Report. A mature reimbursement framework under the Medicare ESRD Prospective Payment System, which covers dialysis services at a finalized base rate of USD 281.71 per treatment for calendar year 2026, provides consistent revenue visibility for both product suppliers and service operators. The region is also home to a concentrated network of dialysis facilities, with approximately 7,600 CMS-recognized ESRD centers and major global industry participants. Asia Pacific is the fastest-growing regional market. China and India are the primary growth engines, with government-backed universal CKD coverage programs and subsidized dialysis access schemes accelerating patient enrollment at dialysis centers in both countries. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the hemodialysis and peritoneal dialysis market. ▪ By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%) ▪ By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%) ▪ By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), Nikkiso Co., Ltd. (Japan), DaVita Inc. (US), Asahi Kasei Medical Co., Ltd. (Japan), Toray Medical Co., Ltd. (Japan), JMS Co., Ltd. (Japan), Outset Medical (US), and Rockwell Medical (US) are some of the key players in the global hemodialysis and peritoneal dialysis market. Study Coverage: This research report categorizes the global hemodialysis and peritoneal dialysis market by product and service (hemodialysis market and peritoneal dialysis market), HD product & service (HD machines, HD consumables & supplies, and HD services), HD machine type (center-use HD machines and home-use HD machines), HD consumables type (dialyzers, bloodlines sets & tubes, hemodialysis concentrates/dialysates, HD access products, and others), HD service type (in-center hemodialysis services and home hemodialysis (HHD) services), PD product & service (PD concentrates/dialysates, PD machines, PD catheters, PD transfer sets, other PD products, and PD services), HD modality (conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis), PD modality [continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)], disease indication (end-stage renal disease (ESRD), acute kidney injury (AKI), and others), end user (hospitals, independent dialysis centers, home care settings, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides detailed information on the key factors driving growth in the global hemodialysis and peritoneal dialysis markets. Key Benefits of Buying this Report ▪ Analysis of Key Drivers, Restraints, Opportunities, and Challenges: Gain insights into the principal factors shaping the global hemodialysis and peritoneal dialysis market, including rising CKD and ESRD prevalence, expanding home dialysis adoption, favorable reimbursement policies, high treatment costs, poor home HD reimbursement in select markets, digital health integration opportunities, and patient compliance challenges. ▪ Market Development: Understand current and projected market sizes across all product, service, modality, disease indication, end-user, and regional segments from 2024 to 2031, with base year data for 2025 and a complete historical series from 2024. ▪ Market Diversification: Identify high-growth pockets including HD access products, home hemodialysis services, home care settings, and the Asia Pacific regional market, along with country-level breakdowns for 20+ markets. ▪ Competitive Assessment: Evaluate the competitive positioning of key players including Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, Nikkiso Co., Ltd., DaVita Inc., Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., JMS Co., Ltd., Outset Medical, and Rockwell Medical, with analysis of their product portfolios, strategies, and recent commercial developments.
目錄 Table of Contents
1 INTRODUCTION 43 1.1 STUDY OBJECTIVES 43 1.2 MARKET DEFINITION 43 1.3 MARKET SCOPE 43 1.3.1 MARKET SEGMENTATION 44 1.4 INCLUSIONS AND EXCLUSIONS 45 1.4.1 YEARS CONSIDERED 46 1.4.2 CURRENCY CONSIDERED 47 1.5 STAKEHOLDERS 47 1.6 LIMITATIONS 47 1.7 SUMMARY OF CHANGES 48 2 EXECUTIVE SUMMARY 49 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 49 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 50 2.3 DISRUPTIVE TRENDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 51 2.4 HIGH-GROWTH SEGMENTS 52 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 53 3 PREMIUM INSIGHTS 55 3.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW 55 3.2 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER AND COUNTRY (2025) 56 3.3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COUNTRY/REGION 57 4 MARKET OVERVIEW 58 4.1 INTRODUCTION 58 4.2 MARKET DYNAMICS 58 4.2.1 DRIVERS 59 4.2.1.1 Rising prevalence of chronic kidney disease and end-stage renal disease 59 4.2.1.2 Increasing aging population susceptible to kidney disorders 60 4.2.1.3 Growing prevalence of diabetes and hypertension 61 4.2.1.4 Continuous technological advancements in dialysis machines and consumables 62 4.2.2 RESTRAINTS 63 4.2.2.1 High cost of dialysis treatment and infrastructure 63 4.2.2.2 Frequent product recalls and quality compliance issues 64 4.2.3 OPPORTUNITIES 65 4.2.3.1 Expansion of dialysis centers and renal care infrastructure 65 4.2.3.2 Investments in healthcare infrastructure in emerging markets 66 4.2.4 CHALLENGES 67 4.2.4.1 Shortage of nephrologists and trained dialysis professionals 67 4.2.4.2 Risk of dialysis-related infections and complications 67 4.3 UNMET NEEDS AND WHITE SPACES 68 4.3.1 UNMET NEEDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 68 4.3.2 WHITE SPACE OPPORTUNITIES 69 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 70 4.4.1 INTERCONNECTED MARKETS 70 4.4.2 CROSS-SECTOR OPPORTUNITIES 71 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 71 4.5.1 STRATEGIC MOVES IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 71 5 INDUSTRY TRENDS 73 5.1 PORTER’S FIVE FORCES ANALYSIS 73 5.1.1 THREAT OF NEW ENTRANTS 74 5.1.2 THREAT OF SUBSTITUTES 75 5.1.3 BARGAINING POWER OF SUPPLIERS 75 5.1.4 BARGAINING POWER OF BUYERS 75 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 75 5.2 MACROECONOMIC INDICATORS 76 5.2.1 INTRODUCTION 76 5.2.2 GDP TRENDS AND FORECAST 76 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 77 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 77 5.3 SUPPLY CHAIN ANALYSIS 78 5.4 VALUE CHAIN ANALYSIS 79 5.5 ECOSYSTEM ANALYSIS 80 5.5.1 MANUFACTURERS 81 5.5.2 END USERS 82 5.5.3 REGULATORY BODIES 82 5.6 PRICING ANALYSIS 83 5.7 TRADE ANALYSIS 87 5.7.1 IMPORT DATA (HS CODE 9018) 87 5.7.2 EXPORT DATA FOR (HS CODE 9018) 88 5.8 REIMBURSEMENT SCENARIO 88 5.9 KEY CONFERENCES AND EVENTS, 2026–2027 89 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90 5.11 INVESTMENT AND FUNDING SCENARIO 90 5.12 CASE STUDY ANALYSIS 91 5.13 IMPACT OF 2025 US TARIFF - HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 93 5.13.1 INTRODUCTION 93 5.13.2 KEY TARIFF RATES 94 5.13.3 PRICE IMPACT ANALYSIS 94 5.13.4 IMPACT ON COUNTRIES/REGIONS 95 5.13.5 IMPACT ON END-USE SEGMENTS 96 5.13.5.1 Hospitals 96 5.13.5.2 Independent dialysis centers 96 5.13.5.3 Home care settings 97 5.13.5.4 Other end users 97 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 98 6.1 TECHNOLOGY ANALYSIS 98 6.1.1 KEY EMERGING TECHNOLOGIES 98 6.1.1.1 High-volume hemodiafiltration (HDF) 98 6.1.1.2 Intelligent home dialysis platforms 98 6.1.2 COMPLEMENTARY TECHNOLOGIES 98 6.1.2.1 Remote patient management platforms 98 6.1.2.2 Advanced dialyzer membrane technology 98 6.1.3 ADJACENT TECHNOLOGIES 99 6.1.3.1 Portable & wearable artificial kidney technologies 99 6.2 TECHNOLOGY/PRODUCT ROADMAP 99 6.2.1 NEAR TERM (2025–2027) 99 6.2.2 MID-TERM (2028–2030) 99 6.2.3 LONG TERM (2030+) 99 6.3 PATENT ANALYSIS 100 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS 100 6.4 FUTURE APPLICATIONS 102 6.4.1 AI-ASSISTED TREATMENT PLANNING AND THERAPY OPTIMIZATION 103 6.4.2 PERSONALIZED DIALYSIS THERAPY 103 6.4.3 CONNECTED DIALYSIS WORKFLOWS AND DIGITAL INTEGRATION 103 6.5 IMPACT OF AI/GEN AI ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 103 6.5.1 INTRODUCTION 103 6.5.2 MARKET POTENTIAL OF AI IN HEMODIALYSIS AND PERITONEAL DIALYSIS 104 6.5.3 AI USE CASES 104 6.5.4 KEY COMPANIES IMPLEMENTING AI 105 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 107 7.1 REGULATORY LANDSCAPE 107 7.1.1 REGULATORY FRAMEWORK 107 7.1.1.1 North America 107 7.1.1.2 Europe 107 7.1.1.3 Asia Pacific 108 7.1.1.4 Latin America 108 7.1.1.5 Middle East & Africa 108 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 7.1.3 INDUSTRY STANDARDS 111 7.2 SUSTAINABILITY INITIATIVES 112 7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING 112 7.2.2 WATER, ENERGY, & RESOURCE EFFICIENCY 112 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 112 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 114 8.1 DECISION-MAKING PROCESS 114 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR CRITERIA 114 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 115 8.2.2 BUYING CRITERIA 116 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 116 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 117 8.5 MARKET PROFITABILITY 118 9 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE 119 9.1 INTRODUCTION 120 9.2 HEMODIALYSIS SERVICES 120 9.2.1 IN—CENTER HEMODIALYSIS SERVICES 122 9.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment 122 9.2.2 HOME HEMODIALYSIS SERVICES 123 9.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth 123 9.3 HEMODIALYSIS PRODUCTS 125 9.3.1 HEMODIALYSIS MACHINES 126 9.3.1.1 Center-use hemodialysis machines 128 9.3.1.1.1 Rising number of renal care centers to aid segment growth 128 9.3.1.1.2 Volume analysis of center-use hemodialysis machines, 2024–2031 (ten thousand units) 130 9.3.1.2 Home-use hemodialysis machines 130 9.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth 130 9.3.1.2.2 Volume analysis of home-use hemodialysis machines, 2024–2031 (ten thousand units) 132 9.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES 132 9.3.2.1 Dialyzers 134 9.3.2.1.1 Dialyzers market, by material 135 9.3.2.1.1.1 Synthetic dialyzers 136 9.3.2.1.1.1.1 High physical strength and increased chemical resistance to drive segment 136 9.3.2.1.1.1.2 Volume analysis of synthetic dialyzers, 2024-2031 (Ten Thousand Units) 138 9.3.2.1.1.2 Cellulose-based dialyzers 138 9.3.2.1.1.2.1 Affordability and high biocompatibility to support segment growth 138 9.3.2.1.1.2.2 volume analysis of cellulose-based dialyzers, 2024-2031 (ten thousand units) 140 9.3.2.1.2 Dialyzers market, by flux 140 9.3.2.1.2.1 High-flux dialyzers 141 9.3.2.1.2.1.1 High-flux dialyzers to command larger market share during forecast period 141 9.3.2.1.2.1.2 Volume analysis of high-flux dialyzers, 2024-2031 (Ten Thousand units) 143 9.3.2.1.2.2 Low-flux dialyzers 143 9.3.2.1.2.2.1 Ability to filter small toxin particles to propel segment growth 143 9.3.2.1.2.2.2 Volume analysis of low-flux dialyzers, 2024-2031 (Ten Thousand Units) 145 9.3.2.2 Bloodline sets and tubes 145 9.3.2.2.1 High pricing and reduced rate of reuse to limit market expansion 145 9.3.2.2.2 Volume analysis of bloodline sets and tubes, 2024-2031 (Ten Thousand Units) 147 9.3.2.3 Concentrates/Dialysates 147 9.3.2.3.1 Alkaline concentrates 149 9.3.2.3.1.1 Growing consumption before dialysis to boost segment growth 149 9.3.2.3.1.2 Volume analysis of alkaline concentrates, 2024-2031 (Ten Thousand Units) 151 9.3.2.3.2 Acidic concentrates 151 9.3.2.3.2.1 Increased number of side effects to limit segment growth 151 9.3.2.3.2.2 Volume analysis of acidic concentrates, 2024-2031 (Ten Thousand Units) 153 9.3.2.4 Access products 153 9.3.2.4.1 AV fistula needles 155 9.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth 155 9.3.2.4.2 AV grafts 157 9.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth 157 9.3.2.4.3 Central venous catheters 158 9.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth 158 9.3.2.5 Other hemodialysis consumables & supplies 161 9.3.2.5.1 Volume analysis of other hemodialysis consumables, 2024-2031 (Ten Thousand Units) 163 9.4 HEMODIALYSIS MARKET, BY MODALITY 163 9.4.1 CONVENTIONAL HEMODIALYSIS 164 9.4.1.1 Technological advancements and rising number of dialysis centers to drive segment 164 9.4.2 SHORT DAILY HEMODIALYSIS 165 9.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth 165 9.4.3 NOCTURNAL HEMODIALYSIS 167 9.4.3.1 Lower procedure costs to aid segment growth 167 9.5 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE 168 9.5.1 CENTRAL WATER DISINFECTION SYSTEMS 170 9.5.1.1 Cost-effectiveness and easy maintenance to drive market 170 9.5.1.1.1 Volume analysis of central water disinfection systems, 2024-2031 (Ten Thousand Units) 172 9.5.2 PORTABLE WATER DISINFECTION SYSTEMS 172 9.5.2.1 User-friendly operations and improved microbiological purity to support segment growth 172 9.5.2.1.1 Volume analysis of portable water disinfection systems, 2024-2031 (Ten Thousand Units) 174 10 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE 175 10.1 INTRODUCTION 176 10.2 PERITONEAL DIALYSIS PRODUCTS 177 10.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 179 10.2.1.1 High demand for concentrates to boost segment growth 179 10.2.1.1.1 Volume analysis of peritoneal dialysis concentrates/ dialysates, 2024-2031 (Ten Thousand Units) 181 10.2.2 PERITONEAL DIALYSIS MACHINES 181 10.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption 181 10.2.2.1.1 Volume analysis of peritoneal dialysis machines, 2024-2031 (Ten Thousand Units) 183 10.2.3 PERITONEAL DIALYSIS CATHETERS 183 10.2.3.1 Favorable reimbursement policies to support market growth 183 10.2.3.1.1 Volume analysis of peritoneal dialysis catheters, 2024-2031 (Ten Thousand Units) 185 10.2.4 PERITONEAL DIALYSIS TRANSFER SETS 185 10.2.4.1 Increasing number of patients in emerging economies to aid market growth 185 10.2.4.1.1 Volume analysis of peritoneal dialysis transfer sets, 2024-2031 (Ten Thousand Units) 187 10.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS 187 10.2.5.1 Volume analysis of other peritoneal dialysis products, 2024-2031 (Ten Thousand Units) 189 10.3 PERITONEAL DIALYSIS SERVICES 189 10.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET 189 10.4 PERITONEAL DIALYSIS MARKET, BY MODALITY 191 10.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 191 10.4.1.1 Superior clearance of high-molecular-weight substances to drive market 191 10.4.2 AUTOMATED PERITONEAL DIALYSIS 192 10.4.2.1 Risk of rapid decline in residual renal functions to limit adoption 192 11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION 194 11.1 INTRODUCTION 195 11.2 END-STAGE RENAL DISEASE 195 11.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET 195 11.3 ACUTE KIDNEY INJURY 196 11.3.1 INCREASING NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH 196 11.4 OTHER INDICATIONS 198 12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER 199 12.1 INTRODUCTION 200 12.2 HOSPITALS 200 12.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET 200 12.3 INDEPENDENT DIALYSIS CENTERS 201 12.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH 201 12.4 HOME CARE SETTINGS 203 12.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH 203 12.5 OTHER END USERS 204 13 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION 206 13.1 INTRODUCTION 207 13.2 NORTH AMERICA 207 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 208 13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 210 13.2.3 US 217 13.2.3.1 US to dominate North American market during study period 217 13.2.4 CANADA 223 13.2.4.1 Shortage of dialysis facilities and increased treatment cost to restrain market expansion 223 13.3 EUROPE 230 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 230 13.3.2 EUROPE: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 231 13.3.3 GERMANY 238 13.3.3.1 Rising number of end-stage renal disease patients to boost market growth 238 13.3.4 UK 244 13.3.4.1 Expanding home dialysis programs and strong NHS support to drive market 244 13.3.5 FRANCE 250 13.3.5.1 Strong reimbursement framework and growing home dialysis adoption to fuel market 250 13.3.6 ITALY 257 13.3.6.1 Universal healthcare coverage and rising CKD burden to support market growth 257 13.3.7 SPAIN 263 13.3.7.1 Increasing CKD prevalence and expanding renal care infrastructure to drive market 263 13.3.8 REST OF EUROPE 269 13.4 ASIA PACIFIC 275 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 276 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 277 13.4.3 CHINA 284 13.4.3.1 Expanding dialysis infrastructure and large CKD patient base to drive market 284 13.4.4 JAPAN 290 13.4.4.1 Advanced dialysis infrastructure and universal reimbursement to support market growth 290 13.4.5 INDIA 296 13.4.5.1 Government-led dialysis expansion and rising CKD burden to fuel market 296 13.4.6 AUSTRALIA 303 13.4.6.1 High adoption of home dialysis and strong healthcare system to support market growth 303 13.4.7 SOUTH KOREA 310 13.4.7.1 Growing CKD burden and expanding renal care services to drive market 310 13.4.8 REST OF ASIA PACIFIC 317 13.5 LATIN AMERICA 323 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 324 13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 325 13.5.3 BRAZIL 332 13.5.3.1 Large dialysis patient base and expanding renal care infrastructure to drive market 332 13.5.4 MEXICO 338 13.5.4.1 Healthcare reforms and expanding access to dialysis to support market growth 338 13.5.5 REST OF LATIN AMERICA 345 13.6 MIDDLE EAST & AFRICA 351 13.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 351 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 352 13.6.3 GCC COUNTRIES 359 13.6.3.1 Kingdom of Saudi Arabia (KSA) 366 13.6.3.1.1 Saudi Vision 2030 and expanding dialysis infrastructure to drive market 366 13.6.3.2 United Arab Emirates (UAE) 373 13.6.3.2.1 Growing investments in renal care and rising CKD burden to support market growth 373 13.6.3.3 Other GCC countries 380 13.6.4 REST OF MIDDLE EAST & AFRICA 387 14 COMPETITIVE LANDSCAPE 394 14.1 OVERVIEW 394 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–JUNE 2026 394 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 395 14.3 REVENUE ANALYSIS 396 14.4 MARKET SHARE ANALYSIS 397 14.4.1 GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025 397 14.4.1.1 US hemodialysis market share analysis, 2025 398 14.4.1.2 Europe hemodialysis market share analysis, 2025 398 14.4.2 GLOBAL PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025 399 14.4.2.1 US peritoneal dialysis market share analysis, 2025 400 14.4.2.2 Europe peritoneal dialysis market share analysis, 2025 401 14.5 BRAND/PRODUCT COMPARISON 404 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 404 14.6.1 STARS 404 14.6.2 EMERGING LEADERS 405 14.6.3 PERVASIVE PLAYERS 405 14.6.4 PARTICIPANTS 405 14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 407 14.6.5.1 Company footprint 407 14.6.5.2 Region footprint 408 14.6.5.3 Hemodialysis product & service footprint 409 14.6.5.4 Hemodialysis modality footprint 410 14.6.5.5 Hemodialysis water treatment system type footprint 410 14.6.5.6 Peritoneal dialysis product & service footprint 411 14.6.5.7 Peritoneal dialysis modality footprint 412 14.6.5.8 Hemodialysis and peritoneal dialysis application footprint 413 14.6.5.9 Hemodialysis and peritoneal dialysis end user footprint 414 14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 414 14.7.1 PROGRESSIVE COMPANIES 414 14.7.2 RESPONSIVE COMPANIES 415 14.7.3 DYNAMIC COMPANIES 415 14.7.4 STARTING BLOCKS 415 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 416 14.7.5.1 Detailed list of key startups/SMEs 416 14.7.5.2 Competitive benchmarking of key startups/SMEs 417 14.8 COMPANY VALUATION AND FINANCIAL METRICS 418 14.8.1 COMPANY VALUATION 418 14.8.2 FINANCIAL METRICS 418 14.9 COMPETITIVE SCENARIO 419 14.9.1 PRODUCT LAUNCHES & APPROVALS 419 14.9.2 DEALS 420 14.9.3 EXPANSIONS 421 14.9.4 OTHER DEVELOPMENTS 421 15 COMPANY PROFILES 422 15.1 KEY PLAYERS 422 15.1.1 FRESENIUS MEDICAL CARE AG 422 15.1.1.1 Business overview 422 15.1.1.2 Products/Solutions/Services offered 423 15.1.1.3 Recent developments 427 15.1.1.3.1 Product launches & approvals 427 15.1.1.3.2 Deals 428 15.1.1.3.3 Expansions 428 15.1.1.3.4 Other developments 428 15.1.1.4 MnM view 429 15.1.1.4.1 Key strengths 429 15.1.1.4.2 Strategic choices 429 15.1.1.4.3 Weaknesses & competitive threats 429 15.1.2 DAVITA INC. 430 15.1.2.1 Business overview 430 15.1.2.2 Products/Solutions/Services offered 431 15.1.2.3 Recent developments 431 15.1.2.3.1 Deals 431 15.1.2.4 MnM view 432 15.1.2.4.1 Key strengths 432 15.1.2.4.2 Strategic choices 432 15.1.2.4.3 Weaknesses & competitive threats 432 15.1.3 VANTIVE 433 15.1.3.1 Business overview 433 15.1.3.2 Products/Solutions/Services offered 433 15.1.3.3 Recent developments 437 15.1.3.3.1 Product launches & approvals 437 15.1.3.3.2 Deals 437 15.1.3.3.3 Expansions 437 15.1.3.3.4 Other developments 438 15.1.3.4 MnM view 438 15.1.3.4.1 Key strengths 438 15.1.3.4.2 Strategic choices 438 15.1.3.4.3 Weaknesses & competitive threats 438 15.1.4 U.S. RENAL CARE, INC. 439 15.1.4.1 Business overview 439 15.1.4.2 Products/Solutions/Services offered 439 15.1.4.3 MnM view 440 15.1.4.3.1 Key strengths 440 15.1.4.3.2 Strategic choices 440 15.1.4.3.3 Weaknesses & competitive threats 440 15.1.5 B. BRAUN SE 441 15.1.5.1 Business overview 441 15.1.5.2 Products/Solutions/Services offered 442 15.1.5.3 Recent developments 445 15.1.5.3.1 Expansions 445 15.1.5.4 MnM view 445 15.1.5.4.1 Key strengths 445 15.1.5.4.2 Strategic choices 445 15.1.5.4.3 Weaknesses & competitive threats 446 15.1.6 NIPRO CORPORATION 447 15.1.6.1 Business overview 447 15.1.6.2 Products/Solutions/Services offered 448 15.1.6.3 Recent developments 451 15.1.6.3.1 Product launches & approvals 451 15.1.6.3.2 Deals 451 15.1.6.3.3 Expansions 452 15.1.7 DIAVERUM AB 453 15.1.7.1 Business overview 453 15.1.7.2 Products/Solutions/Services offered 453 15.1.7.3 Recent developments 454 15.1.7.3.1 Deals 454 15.1.7.3.2 Expansions 455 15.1.8 ASAHI KASEI MEDICAL CO., LTD. 456 15.1.8.1 Business overview 456 15.1.8.2 Products/Solutions/Services offered 456 15.1.8.3 Recent developments 457 15.1.8.3.1 Deals 457 15.1.8.3.2 Other developments 457 15.1.9 TORAY INDUSTRIES, INC. 458 15.1.9.1 Business overview 458 15.1.9.2 Products/Solutions/Services offered 459 15.1.10 NIKKISO CO., LTD. 461 15.1.10.1 Business overview 461 15.1.10.2 Products/Solutions/Services offered 462 15.1.10.3 Recent developments 463 15.1.10.3.1 Product launches & approvals 463 15.1.10.3.2 Deals 464 15.1.11 MOZARC MEDICAL 465 15.1.11.1 Business overview 465 15.1.11.2 Products/Solutions/Services offered 465 15.1.11.3 Recent developments 467 15.1.11.3.1 Deals 467 15.1.12 BD 468 15.1.12.1 Business overview 468 15.1.12.2 Products/Solutions/Services offered 469 15.1.12.3 Recent developments 470 15.1.12.3.1 Deals 470 15.1.12.3.2 Expansions 470 15.1.13 JMS CO., LTD. 471 15.1.13.1 Business overview 471 15.1.13.2 Products/Solutions/Services offered 472 15.1.14 MERIT MEDICAL SYSTEMS 474 15.1.14.1 Business overview 474 15.1.14.2 Products/Solutions/Services offered 475 15.1.14.3 Recent developments 476 15.1.14.3.1 Deals 476 15.1.15 TERUMO CORPORATION 477 15.1.15.1 Business overview 477 15.1.15.2 Products/Solutions/Services offered 478 15.2 OTHER PLAYERS 480 15.2.1 ALLMED MEDICAL PRODUCTS CO., LTD. 480 15.2.2 OUTSET MEDICAL, INC. 481 15.2.3 ROCKWELL MEDICAL, INC. 482 15.2.4 AMERIWATER LLC 483 15.2.5 DIALIFE SA 484 15.2.6 QUANTA DIALYSIS TECHNOLOGIES LTD 485 15.2.7 ISOPURE CORP. 486 15.2.8 POLY MEDICURE LIMITED 487 15.2.9 ATLANTIC BIOMEDICAL 488 15.2.10 AMECATH 489 16 RESEARCH METHODOLOGY 490 16.1 RESEARCH DATA 490 16.1.1 SECONDARY DATA 491 16.1.1.1 Key secondary sources 492 16.1.2 PRIMARY DATA 492 16.1.2.1 Primary sources 493 16.1.2.2 Key data from primary sources 494 16.1.2.3 Key industry insights 494 16.1.2.4 Breakdown of primaries 495 16.2 MARKET SIZE ESTIMATION 496 16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 497 16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 499 16.2.3 APPROACH 3: TOP-DOWN APPROACH 499 16.2.4 APPROACH 4: BOTTOM-UP APPROACH 500 16.2.5 APPROACH 4: PRIMARY INTERVIEWS 500 16.2.6 APPROACH 5: DEMAND-SIDE APPROACH 501 16.2.7 APPROACH 6: VOLUME DATA ANALYSIS 502 16.3 DATA TRIANGULATION AND MARKET BREAKDOWN 505 16.4 MARKET SHARE ASSESSMENT 506 16.5 RESEARCH ASSUMPTIONS 506 16.5.1 STUDY ASSUMPTIONS 506 16.5.2 GROWTH RATE ASSUMPTIONS 506 16.6 RISK ASSESSMENT 507 16.7 RESEARCH LIMITATIONS 507 17 APPENDIX 508 17.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 512 17.2 CUSTOMIZATION OPTIONS 514 17.2.1 PRODUCT ANALYSIS 514 17.2.2 COMPANY INFORMATION 514 17.2.3 GEOGRAPHIC ANALYSIS 514 17.3 RELATED REPORTS 514 17.4 AUTHOR DETAILS 515
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 47 TABLE 2 AGE DISTRIBUTION OF KIDNEY CARE PATIENTS IN BRITISH COLUMBIA, BY TREATMENT MODALITY 61 TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 73 TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION) 76 TABLE 5 LIST OF KEY HEMODIALYSIS AND PERITONEAL DIALYSIS MANUFACTURERS 81 TABLE 6 LIST OF KEY END USERS 82 TABLE 7 LIST OF KEY REGULATORY BODIES 82 TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD) 83 TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 85 TABLE 10 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 87 TABLE 11 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 88 TABLE 12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 89 TABLE 13 HOME PERITONEAL DIALYSIS WITH REMOTE PATIENT MONITORING 91 TABLE 14 HOME HEMODIALYSIS SUPPORTING FULL-TIME EMPLOYMENT 92 TABLE 15 HOME PERITONEAL DIALYSIS FOR VISUALLY IMPAIRED PATIENT 92 TABLE 16 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025 94 TABLE 17 KEY PRODUCT-RELATED TARIFFS 94 TABLE 18 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA 95 TABLE 19 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 95 TABLE 20 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK 96 TABLE 21 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO 96 TABLE 22 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PATENTS, 2023–2025 101 TABLE 23 COMPANIES IMPLEMENTING AI 106 TABLE 24 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 25 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 26 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 27 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 28 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 115 TABLE 30 KEY BUYING CRITERIA FOR END USERS 116 TABLE 31 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: ADOPTION BARRIERS AND INTERNAL CHALLENGES 116 TABLE 32 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 117 TABLE 33 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PROFITABILITY DRIVERS 118 TABLE 34 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 120 TABLE 35 HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 121 TABLE 36 HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 121 TABLE 37 KEY PLAYERS PROVIDING IN—CENTER HEMODIALYSIS SERVICES 122 TABLE 38 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 123 TABLE 39 KEY PLAYERS PROVIDING HOME HEMODIALYSIS SERVICES 124 TABLE 40 HOME HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 124 TABLE 41 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 125 TABLE 42 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 126 TABLE 43 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 127 TABLE 44 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 127 TABLE 45 KEY PLAYERS PROVIDING CENTER-USE HEMODIALYSIS MACHINES 128 TABLE 46 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 129 TABLE 47 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 130 TABLE 48 KEY PLAYERS PROVIDING HOME-USE HEMODIALYSIS MACHINES 131 TABLE 49 HOME-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 131 TABLE 50 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 132 TABLE 51 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 133 TABLE 52 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 134 TABLE 53 DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 135 TABLE 54 DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 136 TABLE 55 KEY PLAYERS PROVIDING SYNTHETIC DIALYZERS 136 TABLE 56 SYNTHETIC DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 137 TABLE 57 SYNTHETIC DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 138 TABLE 58 KEY PLAYERS PROVIDING CELLULOSE-BASED DIALYZERS 138 TABLE 59 CELLULOSE-BASED DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 139 TABLE 60 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 140 TABLE 61 DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 140 TABLE 62 KEY PLAYERS PROVIDING HIGH-FLUX DIALYZERS 141 TABLE 63 HIGH-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 142 TABLE 64 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 143 TABLE 65 KEY PLAYERS PROVIDING LOW-FLUX DIALYZERS 143 TABLE 66 LOW-FLUX DIALYZERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 144 TABLE 67 LOW-FLUX DIALYZERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 145 TABLE 68 KEY PLAYERS PROVIDING BLOODLINE SETS AND TUBES 145 TABLE 69 BLOODLINE SETS AND TUBES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 146 TABLE 70 BLOODLINE SETS AND TUBES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 147 TABLE 71 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 147 TABLE 72 CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 148 TABLE 73 KEY PLAYERS PROVIDING ALKALINE CONCENTRATES 149 TABLE 74 ALKALINE CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 150 TABLE 75 ALKALINE CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 151 TABLE 76 KEY PLAYERS PROVIDING ACIDIC CONCENTRATES 151 TABLE 77 ACIDIC CONCENTRATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 152 TABLE 78 ACIDIC CONCENTRATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 153 TABLE 79 ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 153 TABLE 80 ACCESS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 154 TABLE 81 KEY PLAYERS PROVIDING AV FISTULA NEEDLES 155 TABLE 82 AV FISTULA NEEDLES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 156 TABLE 83 KEY PLAYERS PROVIDING AV GRAFTS 157 TABLE 84 AV GRAFTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 158 TABLE 85 KEY PLAYERS PROVIDING CENTRAL VENOUS CATHETERS 159 TABLE 86 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 160 TABLE 87 KEY PLAYERS PROVIDING OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES 161 TABLE 88 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 162 TABLE 89 OTHER HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 163 TABLE 90 HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 163 TABLE 91 HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION) 165 TABLE 92 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION) 166 TABLE 93 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION) 168 TABLE 94 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 169 TABLE 95 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 169 TABLE 96 KEY PLAYERS PROVIDING CENTRAL WATER DISINFECTION SYSTEMS 170 TABLE 97 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 171 TABLE 98 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 172 TABLE 99 KEY PLAYERS PROVIDING PORTABLE WATER DISINFECTION SYSTEMS 173 TABLE 100 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 173 TABLE 101 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 174 TABLE 102 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 176 TABLE 103 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2024–2031 (USD BILLION) 177 TABLE 104 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY COUNTRY, 2024–2031 (USD BILLION) 178 TABLE 105 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 179 TABLE 106 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 180 TABLE 107 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 181 TABLE 108 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS MACHINES 181 TABLE 109 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 182 TABLE 110 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 183 TABLE 111 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CATHETERS 183 TABLE 112 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 184 TABLE 113 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 185 TABLE 114 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS TRANSFER SETS 185 TABLE 115 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 186 TABLE 116 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 187 TABLE 117 KEY PLAYERS PROVIDING OTHER PERITONEAL DIALYSIS PRODUCTS 187 TABLE 118 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 188 TABLE 119 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2024–2031 (TEN THOUSAND UNITS) 189 TABLE 120 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS SERVICES 189 TABLE 121 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY COUNTRY, 2024–2031 (USD BILLION) 190 TABLE 122 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 191 TABLE 123 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION) 192 TABLE 124 PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2024–2031 (USD BILLION) 193 TABLE 125 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 195 TABLE 126 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY COUNTRY, 2024–2031 (USD BILLION) 196 TABLE 127 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY COUNTRY, 2024–2031 (USD BILLION) 197 TABLE 128 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2024–2031 (USD BILLION) 198 TABLE 129 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 200 TABLE 130 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD BILLION) 201 TABLE 131 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2024–2031 (USD BILLION) 202 TABLE 132 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD BILLION) 204 TABLE 133 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD BILLION) 205 TABLE 134 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2024–2031 (USD BILLION) 207 TABLE 135 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 210 TABLE 136 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 211 TABLE 137 NORTH AMERICA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 211 TABLE 138 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 211 TABLE 139 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 212 TABLE 140 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 212 TABLE 141 NORTH AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 213 TABLE 142 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 213 TABLE 143 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 213 TABLE 144 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 214 TABLE 145 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 214 TABLE 146 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 214 TABLE 147 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 215 TABLE 148 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 215 TABLE 149 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 216 TABLE 150 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 216 TABLE 151 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 217 TABLE 152 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 217 TABLE 153 US: MACROECONOMIC INDICATORS 218 TABLE 154 US: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 218 TABLE 155 US: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 218 TABLE 156 US: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 219 TABLE 157 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 219 TABLE 158 US: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 219 TABLE 159 US: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 220 TABLE 160 US: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 220 TABLE 161 US: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 220 TABLE 162 US: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 221 TABLE 163 US: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 221 TABLE 164 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 221 TABLE 165 US: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 222 TABLE 166 US: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 222 TABLE 167 US: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 222 TABLE 168 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 223 TABLE 169 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 223 TABLE 170 CANADA: MACROECONOMIC INDICATORS 224 TABLE 171 CANADA: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 224 TABLE 172 CANADA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 224 TABLE 173 CANADA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 225 TABLE 174 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 225 TABLE 175 CANADA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 225 TABLE 176 CANADA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 226 TABLE 177 CANADA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 226 TABLE 178 CANADA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 226 TABLE 179 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 227 TABLE 180 CANADA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 227 TABLE 181 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 227 TABLE 182 CANADA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 228 TABLE 183 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 228 TABLE 184 CANADA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 229 TABLE 185 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 229 TABLE 186 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 229 TABLE 187 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 231 TABLE 188 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 232 TABLE 189 EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 232 TABLE 190 EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 232 TABLE 191 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 233 TABLE 192 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 233 TABLE 193 EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 233 TABLE 194 EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 234 TABLE 195 EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 234 TABLE 196 EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 234 TABLE 197 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 235 TABLE 198 EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 235 TABLE 199 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 235 TABLE 200 EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 236 TABLE 201 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 236 TABLE 202 EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 237 TABLE 203 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 237 TABLE 204 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 237 TABLE 205 GERMANY: MACROECONOMIC INDICATORS 238 TABLE 206 GERMANY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 239 TABLE 207 GERMANY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 239 TABLE 208 GERMANY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 239 TABLE 209 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 240 TABLE 210 GERMANY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 240 TABLE 211 GERMANY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 240 TABLE 212 GERMANY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 241 TABLE 213 GERMANY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 241 TABLE 214 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 241 TABLE 215 GERMANY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 242 TABLE 216 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 242 TABLE 217 GERMANY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 242 TABLE 218 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 243 TABLE 219 GERMANY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 243 TABLE 220 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 244 TABLE 221 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 244 TABLE 222 UK: MACROECONOMIC INDICATORS 245 TABLE 223 UK: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 245 TABLE 224 UK: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 245 TABLE 225 UK: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 246 TABLE 226 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 246 TABLE 227 UK: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 246 TABLE 228 UK: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 247 TABLE 229 UK: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 247 TABLE 230 UK: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 247 TABLE 231 UK: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 248 TABLE 232 UK: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 248 TABLE 233 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 248 TABLE 234 UK: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 249 TABLE 235 UK: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 249 TABLE 236 UK: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 249 TABLE 237 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 250 TABLE 238 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 250 TABLE 239 FRANCE: MACROECONOMIC INDICATORS 251 TABLE 240 FRANCE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 251 TABLE 241 FRANCE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 251 TABLE 242 FRANCE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 252 TABLE 243 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 252 TABLE 244 FRANCE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 252 TABLE 245 FRANCE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 253 TABLE 246 FRANCE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 253 TABLE 247 FRANCE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 253 TABLE 248 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 254 TABLE 249 FRANCE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 254 TABLE 250 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 254 TABLE 251 FRANCE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 255 TABLE 252 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 255 TABLE 253 FRANCE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 256 TABLE 254 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 256 TABLE 255 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 256 TABLE 256 ITALY: MACROECONOMIC INDICATORS 257 TABLE 257 ITALY: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 257 TABLE 258 ITALY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 258 TABLE 259 ITALY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 258 TABLE 260 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 258 TABLE 261 ITALY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 259 TABLE 262 ITALY: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 259 TABLE 263 ITALY: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 259 TABLE 264 ITALY: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 260 TABLE 265 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 260 TABLE 266 ITALY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 260 TABLE 267 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 261 TABLE 268 ITALY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 261 TABLE 269 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 261 TABLE 270 ITALY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 262 TABLE 271 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 262 TABLE 272 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 262 TABLE 273 SPAIN: MACROECONOMIC INDICATORS 263 TABLE 274 SPAIN: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 263 TABLE 275 SPAIN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 264 TABLE 276 SPAIN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 264 TABLE 277 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 264 TABLE 278 SPAIN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 265 TABLE 279 SPAIN: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 265 TABLE 280 SPAIN: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 265 TABLE 281 SPAIN: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 266 TABLE 282 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 266 TABLE 283 SPAIN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 266 TABLE 284 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 267 TABLE 285 SPAIN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 267 TABLE 286 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 268 TABLE 287 SPAIN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 268 TABLE 288 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 269 TABLE 289 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 269 TABLE 290 REST OF EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 270 TABLE 291 REST OF EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 270 TABLE 292 REST OF EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 270 TABLE 293 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 271 TABLE 294 REST OF EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 271 TABLE 295 REST OF EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 271 TABLE 296 REST OF EUROPE: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 272 TABLE 297 REST OF EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 272 TABLE 298 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 272 TABLE 299 REST OF EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 273 TABLE 300 REST OF EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 273 TABLE 301 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 273 TABLE 302 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 274 TABLE 303 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 274 TABLE 304 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 275 TABLE 305 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 275 TABLE 306 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 277 TABLE 307 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 278 TABLE 308 ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 278 TABLE 309 ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 278 TABLE 310 ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 279 TABLE 311 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 279 TABLE 312 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 279 TABLE 313 ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 280 TABLE 314 ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 280 TABLE 315 ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 280 TABLE 316 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 281 TABLE 317 ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 281 TABLE 318 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 281 TABLE 319 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 282 TABLE 320 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 282 TABLE 321 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 283 TABLE 322 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 283 TABLE 323 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 283 TABLE 324 CHINA: MACROECONOMIC INDICATORS 284 TABLE 325 CHINA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 284 TABLE 326 CHINA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 285 TABLE 327 CHINA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 285 TABLE 328 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 285 TABLE 329 CHINA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 286 TABLE 330 CHINA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 286 TABLE 331 CHINA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 286 TABLE 332 CHINA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 287 TABLE 333 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 287 TABLE 334 CHINA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 287 TABLE 335 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 288 TABLE 336 CHINA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 288 TABLE 337 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 288 TABLE 338 CHINA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 289 TABLE 339 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 289 TABLE 340 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 289 TABLE 341 JAPAN: MACROECONOMIC INDICATORS 290 TABLE 342 JAPAN: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 290 TABLE 343 JAPAN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 291 TABLE 344 JAPAN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 291 TABLE 345 JAPAN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 291 TABLE 346 JAPAN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 292 TABLE 347 JAPAN: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 292 TABLE 348 JAPAN: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 292 TABLE 349 JAPAN: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 293 TABLE 350 JAPAN: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 293 TABLE 351 JAPAN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 293 TABLE 352 JAPAN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 294 TABLE 353 JAPAN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 294 TABLE 354 JAPAN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 295 TABLE 355 JAPAN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 295 TABLE 356 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 296 TABLE 357 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 296 TABLE 358 INDIA: MACROECONOMIC INDICATORS 297 TABLE 359 INDIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 297 TABLE 360 INDIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 297 TABLE 361 INDIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 298 TABLE 362 INDIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 298 TABLE 363 INDIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 299 TABLE 364 INDIA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 299 TABLE 365 INDIA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 299 TABLE 366 INDIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 300 TABLE 367 INDIA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 300 TABLE 368 INDIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 300 TABLE 369 INDIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 301 TABLE 370 INDIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 301 TABLE 371 INDIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 302 TABLE 372 INDIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 302 TABLE 373 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 303 TABLE 374 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 303 TABLE 375 AUSTRALIA: MACROECONOMIC INDICATORS 304 TABLE 376 AUSTRALIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 304 TABLE 377 AUSTRALIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 304 TABLE 378 AUSTRALIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 305 TABLE 379 AUSTRALIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 305 TABLE 380 AUSTRALIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 306 TABLE 381 AUSTRALIA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 306 TABLE 382 AUSTRALIA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 306 TABLE 383 AUSTRALIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 307 TABLE 384 AUSTRALIA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 307 TABLE 385 AUSTRALIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 307 TABLE 386 AUSTRALIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 308 TABLE 387 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 308 TABLE 388 AUSTRALIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 309 TABLE 389 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 309 TABLE 390 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 310 TABLE 391 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 310 TABLE 392 SOUTH KOREA: MACROECONOMIC INDICATORS 311 TABLE 393 SOUTH KOREA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 311 TABLE 394 SOUTH KOREA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 311 TABLE 395 SOUTH KOREA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 312 TABLE 396 SOUTH KOREA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 312 TABLE 397 SOUTH KOREA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 313 TABLE 398 SOUTH KOREA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 313 TABLE 399 SOUTH KOREA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 313 TABLE 400 SOUTH KOREA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 314 TABLE 401 SOUTH KOREA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 314 TABLE 402 SOUTH KOREA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 314 TABLE 403 SOUTH KOREA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 315 TABLE 404 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 315 TABLE 405 SOUTH KOREA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 316 TABLE 406 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 316 TABLE 407 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 317 TABLE 408 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 317 TABLE 409 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 318 TABLE 410 REST OF ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 318 TABLE 411 REST OF ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 318 TABLE 412 REST OF ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 319 TABLE 413 REST OF ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 319 TABLE 414 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 319 TABLE 415 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 320 TABLE 416 REST OF ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 320 TABLE 417 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 320 TABLE 418 REST OF ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 321 TABLE 419 REST OF ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 321 TABLE 420 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 321 TABLE 421 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 322 TABLE 422 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 322 TABLE 423 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 323 TABLE 424 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 323 TABLE 425 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 325 TABLE 426 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 326 TABLE 427 LATIN AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 326 TABLE 428 LATIN AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 326 TABLE 429 LATIN AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 327 TABLE 430 LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 327 TABLE 431 LATIN AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 327 TABLE 432 LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 328 TABLE 433 LATIN AMERICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 328 TABLE 434 LATIN AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 328 TABLE 435 LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 329 TABLE 436 LATIN AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 329 TABLE 437 LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 329 TABLE 438 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 330 TABLE 439 LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 330 TABLE 440 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 331 TABLE 441 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 331 TABLE 442 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 331 TABLE 443 BRAZIL: MACROECONOMIC INDICATORS 332 TABLE 444 BRAZIL: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 332 TABLE 445 BRAZIL: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 333 TABLE 446 BRAZIL: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 333 TABLE 447 BRAZIL: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 333 TABLE 448 BRAZIL: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 334 TABLE 449 BRAZIL: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 334 TABLE 450 BRAZIL: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 334 TABLE 451 BRAZIL: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 335 TABLE 452 BRAZIL: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 335 TABLE 453 BRAZIL: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 335 TABLE 454 BRAZIL: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 336 TABLE 455 BRAZIL: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 336 TABLE 456 BRAZIL: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 337 TABLE 457 BRAZIL: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 337 TABLE 458 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 338 TABLE 459 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 338 TABLE 460 MEXICO: MACROECONOMIC INDICATORS 339 TABLE 461 MEXICO: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 339 TABLE 462 MEXICO: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 339 TABLE 463 MEXICO: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 340 TABLE 464 MEXICO: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 340 TABLE 465 MEXICO: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 340 TABLE 466 MEXICO: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 341 TABLE 467 MEXICO: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 341 TABLE 468 MEXICO: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 341 TABLE 469 MEXICO: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 342 TABLE 470 MEXICO: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 342 TABLE 471 MEXICO: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 342 TABLE 472 MEXICO: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 343 TABLE 473 MEXICO: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 343 TABLE 474 MEXICO: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 344 TABLE 475 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 344 TABLE 476 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 344 TABLE 477 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 345 TABLE 478 REST OF LATIN AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 345 TABLE 479 REST OF LATIN AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 346 TABLE 480 REST OF LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 346 TABLE 481 REST OF LATIN AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 346 TABLE 482 REST OF LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 347 TABLE 483 REST OF LATIN AMERICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 347 TABLE 484 REST OF LATIN AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 347 TABLE 485 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 348 TABLE 486 REST OF LATIN AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 348 TABLE 487 REST OF LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 348 TABLE 488 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 349 TABLE 489 REST OF LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 349 TABLE 490 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 350 TABLE 491 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 350 TABLE 492 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 350 TABLE 493 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 352 TABLE 494 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 353 TABLE 495 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 353 TABLE 496 MIDDLE EAST & AFRICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 353 TABLE 497 MIDDLE EAST & AFRICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 354 TABLE 498 MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 354 TABLE 499 MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 355 TABLE 500 MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 355 TABLE 501 MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 355 TABLE 502 MIDDLE EAST & AFRICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 356 TABLE 503 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 356 TABLE 504 MIDDLE EAST & AFRICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 356 TABLE 505 MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 357 TABLE 506 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 357 TABLE 507 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 358 TABLE 508 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 358 TABLE 509 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 359 TABLE 510 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 359 TABLE 511 GCC COUNTRIES: HEMODIALYSIS MARKET, BY COUNTRY, 2024–2031 (USD BILLION) 360 TABLE 512 GCC COUNTRIES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 360 TABLE 513 GCC COUNTRIES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 360 TABLE 514 GCC COUNTRIES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 361 TABLE 515 GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 361 TABLE 516 GCC COUNTRIES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 362 TABLE 517 GCC COUNTRIES: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 362 TABLE 518 GCC COUNTRIES: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 362 TABLE 519 GCC COUNTRIES: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 363 TABLE 520 GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 363 TABLE 521 GCC COUNTRIES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 363 TABLE 522 GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 364 TABLE 523 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 364 TABLE 524 GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 365 TABLE 525 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 365 TABLE 526 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 366 TABLE 527 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 366 TABLE 528 KINGDOM OF SAUDI ARABIA: KEY MACRO INDICATORS 367 TABLE 529 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 367 TABLE 530 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 367 TABLE 531 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 368 TABLE 532 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 368 TABLE 533 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 369 TABLE 534 KINGDOM OF SAUDI ARABIA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 369 TABLE 535 KINGDOM OF SAUDI ARABIA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 369 TABLE 536 KINGDOM OF SAUDI ARABIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 370 TABLE 537 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 370 TABLE 538 KINGDOM OF SAUDI ARABIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 370 TABLE 539 KINGDOM OF SAUDI ARABIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 371 TABLE 540 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 371 TABLE 541 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 372 TABLE 542 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 372 TABLE 543 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 373 TABLE 544 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 373 TABLE 545 UNITED ARAB EMIRATES: KEY MACRO INDICATORS 374 TABLE 546 UNITED ARAB EMIRATES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 374 TABLE 547 UNITED ARAB EMIRATES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 374 TABLE 548 UNITED ARAB EMIRATES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 375 TABLE 549 UNITED ARAB EMIRATES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 375 TABLE 550 UNITED ARAB EMIRATES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 376 TABLE 551 UNITED ARAB EMIRATES: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 376 TABLE 552 UNITED ARAB EMIRATES: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 376 TABLE 553 UNITED ARAB EMIRATES: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 377 TABLE 554 UNITED ARAB EMIRATES: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 377 TABLE 555 UNITED ARAB EMIRATES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 377 TABLE 556 UNITED ARAB EMIRATES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 378 TABLE 557 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 378 TABLE 558 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 379 TABLE 559 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 379 TABLE 560 UNITED ARAB EMIRATES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 380 TABLE 561 UNITED ARAB EMIRATES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 380 TABLE 562 OTHER GCC COUNTRIES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 381 TABLE 563 OTHER GCC COUNTRIES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 381 TABLE 564 OTHER GCC COUNTRIES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 381 TABLE 565 OTHER GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 382 TABLE 566 OTHER GCC COUNTRIES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 382 TABLE 567 OTHER GCC COUNTRIES: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 383 TABLE 568 OTHER GCC COUNTRIES: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 383 TABLE 569 OTHER GCC COUNTRIES: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 383 TABLE 570 OTHER GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 384 TABLE 571 OTHER GCC COUNTRIES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 384 TABLE 572 OTHER GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 384 TABLE 573 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 385 TABLE 574 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 385 TABLE 575 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 386 TABLE 576 OTHER GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 386 TABLE 577 OTHER GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 386 TABLE 578 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 387 TABLE 579 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD BILLION) 387 TABLE 580 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 388 TABLE 581 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024–2031 (USD BILLION) 388 TABLE 582 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024–2031 (USD BILLION) 389 TABLE 583 REST OF MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY MATERIAL, 2024–2031 (USD BILLION) 389 TABLE 584 REST OF MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY FLUX, 2024–2031 (USD BILLION) 390 TABLE 585 REST OF MIDDLE EAST & AFRICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 390 TABLE 586 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2024–2031 (USD BILLION) 390 TABLE 587 REST OF MIDDLE EAST & AFRICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024–2031 (USD BILLION) 391 TABLE 588 REST OF MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD BILLION) 391 TABLE 589 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD BILLION) 391 TABLE 590 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD BILLION) 392 TABLE 591 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031 (USD BILLION) 392 TABLE 592 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024–2031 (USD BILLION) 393 TABLE 593 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024–2031 (USD BILLION) 393 TABLE 594 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MARKET PLAYERS, 2023–JUNE 2026 395 TABLE 595 GLOBAL HEMODIALYSIS MARKET: DEGREE OF COMPETITION 397 TABLE 596 US HEMODIALYSIS MARKET: DEGREE OF COMPETITION 398 TABLE 597 EUROPE HEMODIALYSIS MARKET: DEGREE OF COMPETITION 399 TABLE 598 GLOBAL PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION 400 TABLE 599 US PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION 401 TABLE 600 EUROPE PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION 402 TABLE 601 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGION FOOTPRINT 408 TABLE 602 HEMODIALYSIS MARKET: HEMODIALYSIS PRODUCT & SERVICE FOOTPRINT 409 TABLE 603 HEMODIALYSIS MARKET: MODALITY FOOTPRINT 410 TABLE 604 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET: TYPE FOOTPRINT 410 TABLE 605 PERITONEAL DIALYSIS MARKET: PRODUCT & SERVICE FOOTPRINT 411 TABLE 606 PERITONEAL DIALYSIS MARKET: MODALITY FOOTPRINT 412 TABLE 607 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: APPLICATION FOOTPRINT 413 TABLE 608 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: END USER FOOTPRINT 414 TABLE 609 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 416 TABLE 610 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 417 TABLE 611 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, 2023–JUNE 2026 419 TABLE 612 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEALS, 2023–JUNE 2026 420 TABLE 613 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: EXPANSIONS, 2023–JUNE 2026 421 TABLE 614 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OTHER DEVELOPMENTS, 2023–JUNE 2026 421 TABLE 615 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 422 TABLE 616 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 423 TABLE 617 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES & APPROVALS 427 TABLE 618 FRESENIUS MEDICAL CARE AG: DEALS 428 TABLE 619 FRESENIUS MEDICAL CARE AG: EXPANSIONS 428 TABLE 620 FRESENIUS MEDICAL CARE AG: OTHER DEVELOPMENTS 428 TABLE 621 DAVITA INC.: COMPANY OVERVIEW 430 TABLE 622 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 431 TABLE 623 DAVITA INC.: DEALS 431 TABLE 624 VANTIVE: COMPANY OVERVIEW 433 TABLE 625 VANTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 433 TABLE 626 VANTIVE: PRODUCT LAUNCHES & APPROVALS 437 TABLE 627 VANTIVE: DEALS 437 TABLE 628 VANTIVE: EXPANSIONS 437 TABLE 629 VANTIVE: OTHER DEVELOPMENTS 438 TABLE 630 US RENAL CARE, INC.: COMPANY OVERVIEW 439 TABLE 631 US RENAL CARE, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 439 TABLE 632 B. BRAUN SE: COMPANY OVERVIEW 441 TABLE 633 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 442 TABLE 634 B. BRAUN SE: EXPANSIONS 445 TABLE 635 NIPRO CORPORATION: COMPANY OVERVIEW 447 TABLE 636 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 448 TABLE 637 NIPRO CORPORATION: PRODUCT LAUNCHES & APPROVALS 451 TABLE 638 NIPRO CORPORATION: DEALS 451 TABLE 639 NIPRO CORPORATION: EXPANSIONS 452 TABLE 640 DIAVERUM AB: COMPANY OVERVIEW 453 TABLE 641 DIAVERUM AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 453 TABLE 642 DIAVERUM AB: DEALS 454 TABLE 643 DIAVERUM AB: EXPANSIONS 455 TABLE 644 ASAHI KASEI MEDICAL CO., LTD.: COMPANY OVERVIEW 456 TABLE 645 ASAHI KASEI MEDICAL CO., LTD.: PRODUCTS OFFERED 456 TABLE 646 ASAHI KASEI MEDICAL CO., LTD.: DEALS 457 TABLE 647 ASAHI KASEI MEDICAL CO., LTD.: OTHER DEVELOPMENTS 457 TABLE 648 TORAY INDUSTRIES, INC.: COMPANY OVERVIEW 458 TABLE 649 TORAY INDUSTRIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 459 TABLE 650 NIKKISO CO., LTD.: COMPANY OVERVIEW 461 TABLE 651 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 462 TABLE 652 NIKKISO CO., LTD.: PRODUCT LAUNCHES & APPROVALS 463 TABLE 653 NIKKISO CO., LTD.: DEALS 464 TABLE 654 MOZARC MEDICAL: COMPANY OVERVIEW 465 TABLE 655 MOZARC MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 465 TABLE 656 MOZARC MEDICAL: DEALS 467 TABLE 657 BD: COMPANY OVERVIEW 468 TABLE 658 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 469 TABLE 659 BD: DEALS 470 TABLE 660 BD: EXPANSIONS 470 TABLE 661 JMS CO., LTD.: COMPANY OVERVIEW 471 TABLE 662 JMS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 472 TABLE 663 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 474 TABLE 664 MERIT MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 475 TABLE 665 MERIT MEDICAL SYSTEMS: DEALS 476 TABLE 666 TERUMO CORPORATION: COMPANY OVERVIEW 477 TABLE 667 TERUMO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 478 TABLE 668 ALLMED MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW 480 TABLE 669 OUTSET MEDICAL, INC.: COMPANY OVERVIEW 481 TABLE 670 ROCKWELL MEDICAL, INC.: COMPANY OVERVIEW 482 TABLE 671 AMERIWATER LLC: COMPANY OVERVIEW 483 TABLE 672 DIALIFE SA: COMPANY OVERVIEW 484 TABLE 673 QUANTA DIALYSIS TECHNOLOGIES LTD: COMPANY OVERVIEW 485 TABLE 674 ISOPURE CORP.: COMPANY OVERVIEW 486 TABLE 675 POLY MEDICURE LIMITED: COMPANY OVERVIEW 487 TABLE 676 ATLANTIC BIOMEDICAL: COMPANY OVERVIEW 488 TABLE 677 AMECATH: COMPANY OVERVIEW 489 TABLE 678 STUDY ASSUMPTIONS 506 TABLE 679 RISK ASSESSMENT ANALYSIS 507 FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SEGMENTATION 44 FIGURE 2 MARKET SCENARIO 49 FIGURE 3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2024–2031 50 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2023–2025 51 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 51 FIGURE 6 HIGH-GROWTH SEGMENTS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2026–2031 52 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD 53 FIGURE 8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET TRENDS SIGNAL STRONG FUTURE FOR HOME-BASED AND ADVANCED DIALYSIS THERAPIES 55 FIGURE 9 INDEPENDENT DIALYSIS CENTERS SEGMENT AND CHINA DOMINATED MARKET IN 2025 56 FIGURE 10 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 57 FIGURE 11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 FIGURE 12 PERCENTAGE OF US ADULTS AGED 18 YEARS AND OLDER WITH CKD, BY AGE, SEX, AND RACE-ETHNICITY 60 FIGURE 13 PERCENTAGE OF CKD AMONG US ADULTS WITH DIABETES AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY 62 FIGURE 14 PERCENTAGE OF CKD AMONG US ADULTS WITH HIGH BLOOD PRESSURE AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY 62 FIGURE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 74 FIGURE 16 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS 78 FIGURE 17 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS 79 FIGURE 18 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET ECOSYSTEM 81 FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025 (USD) 84 FIGURE 20 AVERAGE SELLING PRICE, BY REGION, 2025 (USD) 87 FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS DEVICES MARKET 90 FIGURE 22 INVESTMENT AND FUNDING SCENARIO 91 FIGURE 23 PATENTS APPLIED AND GRANTED, 2015–JUNE 2026 100 FIGURE 24 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: AI USE CASES 105 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 115 FIGURE 26 KEY BUYING CRITERIA FOR END USERS 116 FIGURE 27 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT 209 FIGURE 28 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT 276 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2023−2025) 396 FIGURE 30 GLOBAL HEMODIALYSIS MARKET SHARE, 2025 397 FIGURE 31 US HEMODIALYSIS MARKET SHARE, 2025 398 FIGURE 32 EUROPE HEMODIALYSIS MARKET SHARE, 2025 399 FIGURE 33 GLOBAL PERITONEAL DIALYSIS MARKET SHARE, 2025 400 FIGURE 34 US PERITONEAL DIALYSIS MARKET SHARE, 2025 401 FIGURE 35 EUROPE PERITONEAL DIALYSIS MARKET SHARE, 2025 402 FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 404 FIGURE 37 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 406 FIGURE 38 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (1/2) 407 FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (2/2) 408 FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 415 FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 418 FIGURE 42 EV/EBITDA OF KEY VENDORS 418 FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2025) 423 FIGURE 44 DAVITA INC.: COMPANY SNAPSHOT (2025) 430 FIGURE 45 B. BRAUN SE: COMPANY SNAPSHOT (2025) 442 FIGURE 46 NIPRO CORPORATION: COMPANY SNAPSHOT (2025) 448 FIGURE 47 TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT (2025) 459 FIGURE 48 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2025) 462 FIGURE 49 BD: COMPANY SNAPSHOT (2025) 469 FIGURE 50 JMS CO., LTD.: COMPANY SNAPSHOT (2025) 472 FIGURE 51 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025) 475 FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2025) 478 FIGURE 53 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: RESEARCH DESIGN 490 FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 495 FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 495 FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 496 FIGURE 57 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 497 FIGURE 58 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 498 FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: B BRAUN (2025) 499 FIGURE 60 TOP-DOWN APPROACH 500 FIGURE 61 BOTTOM-UP APPROACH 500 FIGURE 62 DEMAND-SIDE APPROACH 502 FIGURE 63 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2026–2031) 503 FIGURE 64 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 504 FIGURE 65 DATA TRIANGULATION METHODOLOGY 505

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們